344 related articles for article (PubMed ID: 29119735)
1. Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles: formulation, antimalarial and toxicity assessments.
Dauda K; Busari Z; Morenikeji O; Afolayan F; Oyeyemi O; Meena J; Sahu D; Panda A
J Zhejiang Univ Sci B; 2017 Nov.; 18(11):977-985. PubMed ID: 29119735
[TBL] [Abstract][Full Text] [Related]
2. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
[TBL] [Abstract][Full Text] [Related]
3. Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-D,L-lactide-co-glycolide (PLGA) nanoparticles.
Nguyen HT; Tran TH; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2015; 38(5):716-24. PubMed ID: 24968925
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-Artesunate Based Polymeric Nanoparticle; Antiplasmodial and Toxicological Evaluation in Murine Model.
Oyeyemi O; Morenkeji O; Afolayan F; Dauda K; Busari Z; Meena J; Panda A
Front Pharmacol; 2018; 9():562. PubMed ID: 29899700
[TBL] [Abstract][Full Text] [Related]
5. Development of electrosprayed artesunate-loaded core-shell nanoparticles.
Ho HN; Laidmäe I; Kogermann K; Lust A; Meos A; Nguyen CN; Heinämäki J
Drug Dev Ind Pharm; 2017 Jul; 43(7):1134-1142. PubMed ID: 28277847
[TBL] [Abstract][Full Text] [Related]
6. Antiplasmodial Activity and Toxicological Assessment of Curcumin PLGA-Encapsulated Nanoparticles.
Busari ZA; Dauda KA; Morenikeji OA; Afolayan F; Oyeyemi OT; Meena J; Sahu D; Panda AK
Front Pharmacol; 2017; 8():622. PubMed ID: 28932197
[TBL] [Abstract][Full Text] [Related]
7. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
Ray S; Ghosh Ray S; Mandal S
Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
9. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
[TBL] [Abstract][Full Text] [Related]
11. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
12. Preferential hepatic uptake of paclitaxel-loaded poly-(d-l-lactide-co-glycolide) nanoparticles - A possibility for hepatic drug targeting: Pharmacokinetics and biodistribution.
Mandal D; Shaw TK; Dey G; Pal MM; Mukherjee B; Bandyopadhyay AK; Mandal M
Int J Biol Macromol; 2018 Jun; 112():818-830. PubMed ID: 29421493
[TBL] [Abstract][Full Text] [Related]
13. Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.
Tran TH; Nguyen TD; Van Nguyen H; Nguyen HT; Kim JO; Yong CS; Nguyen CN
Arch Pharm Res; 2016 May; 39(5):687-94. PubMed ID: 27015824
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
[TBL] [Abstract][Full Text] [Related]
15. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and evaluation of the anti-malaria properties of sustained release artesunate-loaded solid lipid microparticles based on phytolipids.
Chinaeke EE; Chime SA; Onyishi VI; Attama AA; Okore VC
Drug Deliv; 2015; 22(5):652-65. PubMed ID: 24479677
[TBL] [Abstract][Full Text] [Related]
17. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
18. Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.
Pandey S; Vijayendra Swamy SM; Ubaid Ulla UM; Gupta A; Patel H; Yadav JS
Curr Drug Deliv; 2017 Sep; 14(6):887-899. PubMed ID: 27538461
[TBL] [Abstract][Full Text] [Related]
19. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
[TBL] [Abstract][Full Text] [Related]
20. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]